Home » Newsletters » BioWorld Science

BioWorld Science

March 6, 2014

View Archived Issues

Researchers describe mechanism of action of ProHema

Acucela completes enrollment in SEATTLE study of emixustat

Targeting the self-renewal of cancer-initiating cells as a new approach for colorectal cancer

Janssen Pharmaceutica designs new agents for pain

Novel SYK inhibitors synthesized at Novartis

Proteostasis Therapeutics and Cystic Fibrosis Foundation Therapeutics extend collaboration

Cellectar Biosciences begins phase II imaging trial of [124I]CLR-1404

Genticel begins phase II trial in women with high-risk HPV

New milestone reached in Genfit and Sanofi's research collaboration

Viriom begins new program for chronic hepatitis B

International Stem Cell reports interim data from stem cell primate study for Parkinson's disease

Astex receives milestone payment as LEE-011 enters phase III trial

Eisai and Biogen Idec to collaborate in Alzheimer's disease

High 12-week sustained virological response rates in PEARL III study

Vaginal dapivirine effectively protects against HIV challenge

Novartis reports novel SMN modulators for spinal muscular atrophy

New KOR-1 antagonists patented by the Scripps Research Institute

FDA accepts additional Lymphoseek supplemental NDA for review

Kamada initiates phase II/III trials with intravenous Glassia for the treatment of type 1 diabetes

FDA issues complete response letter for empagliflozin

Next-generation sequencing for a rare cancer

Janssen Biotech to begin phase III study of daratumumab in multiple myeloma

FDA grants fast track designation to Tekmira's TKM-Ebola

Regulus Therapeutics initiates phase I study of RG-101

Agenus selects modulator antibodies to advance into preclinical development

iCo Therapeutics updates progress of iDEAL study of iCo-007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...